Paper41516183
Metabolic and Antioxidant Modulation by Artemisia indica Willd. Aqueous Extract in Glucose and Cholesterol Dysregulation.
Tseng CY and 5 others. Int J Mol Sci, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Metabolic and Antioxidant Modulation by Artemisia indica Willd. Aqueous Extract in Glucose and Cholesterol Dysregulation. Papers, record 41516183. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41516183
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Metabolic and Antioxidant Modulation by Artemisia indica Willd. Aqueous Extract in Glucose and Cholesterol Dysregulation.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Artemisia | Major topic |
| Plant Extracts | Major topic |
| Antioxidants | Major topic |
| Cholesterol | Major topic |
| Glucose | Major topic |
| Animals | |
| Mice | |
| Oxidative Stress | |
| Lipid Metabolism | |
| Male | |
| Diet, High-Fat | |
| Blood Glucose | |
| Dyslipidemias |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MOST106-2320-B040-010 | Ministry of Science and Technology, Taiwan | PubMed |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39021815 | Herbal Products as Complementary or Alternative Medicine for the Management of Hyperglycemia and Dyslipidemia in Patients with Type 2 Diabetes: Current Evidence Based on Findings of Interventional Studies. | J Nutr Metab | 2024 | https://conductscience.org/library/papers/39021815 | PubMed |
| 2 | 24074449 | Comparative study of non-high density lipoproteins cholesterol level and lipid profile in pre-diabetic and diabetic patients. | CNS Neurol Disord Drug Targets | 2014 | https://conductscience.org/library/papers/24074449 | PubMed |
| 3 | 34981522 | In vitro and in vivo ameliorative effects of polyphenols from purple potato leaves on renal injury and associated inflammation induced by hyperuricemia. | J Food Biochem | 2022 | https://conductscience.org/library/papers/34981522 | PubMed |
| 4 | 32529753 | Reduction in Circulating Advanced Glycation End Products by Mediterranean Diet Is Associated with Increased Likelihood of Type 2 Diabetes Remission in Patients with Coronary Heart Disease: From the Cordioprev Study. | Mol Nutr Food Res | 2021 | https://conductscience.org/library/papers/32529753 | PubMed |
| 5 | 33547567 | IL-10 Deficiency Aggravates Renal Inflammation, Fibrosis and Functional Failure in High-Fat Dieted Obese Mice. | Tissue Eng Regen Med | 2021 | https://conductscience.org/library/papers/33547567 | PubMed |
| 6 | 35891716 | Significance of Lipid Profile Parameters in Predicting Pre-Diabetes. | Arch Razi Inst | 2022 | https://conductscience.org/library/papers/35891716 | PubMed |
| 7 | 34604258 | Qing-Re-Xiao-Zheng Formula Modulates Gut Microbiota and Inhibits Inflammation in Mice With Diabetic Kidney Disease. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/34604258 | PubMed |
| 8 | 34209690 | Hidrox® and Chronic Cystitis: Biochemical Evaluation of Inflammation, Oxidative Stress, and Pain. | Antioxidants (Basel) | 2021 | https://conductscience.org/library/papers/34209690 | PubMed |
| 9 | 37649296 | The Role of Aldose Reductase in Polyol Pathway: An Emerging Pharmacological Target in Diabetic Complications and Associated Morbidities. | Curr Pharm Biotechnol | 2024 | https://conductscience.org/library/papers/37649296 | PubMed |
| 10 | 36214941 | Pre-diabetes, Diabetes, Hyperglycemia, and Stroke: Bittersweet Therapeutic Opportunities. | Curr Neurol Neurosci Rep | 2022 | https://conductscience.org/library/papers/36214941 | PubMed |
| 11 | 32156650 | Protective effect of ginsenoside Rg5 against kidney injury via inhibition of NLRP3 inflammasome activation and the MAPK signaling pathway in high-fat diet/streptozotocin-induced diabetic mice. | Pharmacol Res | 2020 | https://conductscience.org/library/papers/32156650 | PubMed |
| 12 | 21873946 | The concentration of thiobarbituric acid reactive substances (TBARS) and paraoxonase activity in blood of patients with osteoarthrosis after endoprosthesis implantation. | Med Sci Monit | 2011 | https://conductscience.org/library/papers/21873946 | PubMed |
| 13 | 24252495 | Evaluation of antidiabetic and antihyperlipidemic activity of Artemisia indica linn (aeriel parts) in Streptozotocin induced diabetic rats. | J Ethnopharmacol | 2014 | https://conductscience.org/library/papers/24252495 | PubMed |
| 14 | 23702831 | Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease. | Nat Protoc | 2013 | https://conductscience.org/library/papers/23702831 | PubMed |
| 15 | 35243916 | Promoting Plant-Based Therapies for Chronic Kidney Disease. | J Evid Based Integr Med | 2022 | https://conductscience.org/library/papers/35243916 | PubMed |
| 16 | 38671931 | Hormetic Nutrition and Redox Regulation in Gut-Brain Axis Disorders. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/38671931 | PubMed |
| 17 | 23265542 | Chemical composition, antimicrobial, cytotoxic and antioxidant activities of the essential oil of Artemisia indica Willd. | Food Chem | 2013 | https://conductscience.org/library/papers/23265542 | PubMed |
| 18 | 40810065 | Research progress in the treatment of lipid metabolism disorder in patients with diabetic kidney disease by the integrated traditional Chinese and Western medicine. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/40810065 | PubMed |
| 19 | 23117091 | Evaluation of anti-nociceptive, anti-inflammatory and antipyretic activities of Artemisia scoparia hydromethanolic extract. | J Ethnopharmacol | 2013 | https://conductscience.org/library/papers/23117091 | PubMed |
| 20 | 29581743 | Tripterygium wilfordii mitigates hyperglycemia-induced upregulated Wnt/β-catenin expression and kidney injury in diabetic rats. | Exp Ther Med | 2018 | https://conductscience.org/library/papers/29581743 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42292845 | Dicaffeoylquinic acid alleviates alcoholic liver disease by targeting PLA2G4B and inhibiting the MAPK signaling pathway. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42292845 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41516183
GET https://conductscience.org/api/papers/v1/41516183/references?page=2